Acute promyelocytic leukaemia (APL): Difference between revisions

(12 intermediate revisions by 3 users not shown)

Line 1:

{{ICD10 transition status

| OldDxArticle =| CurrentStatus = ~~freshly automatically generated article~~

| OldDxArticle =

| CurrentStatus = reconciled

| InitialEditorAssigned = Debbie Page-Newton

~~| MinimumCombinedCodes =~~

}}

{{ICD10 dx

| MinimumCombinedCodes =

| ICD10 Code=C92.4

| BugRequired=

}}

~~{{ICD10 category|Heme/immunology}}{{ICD10 category|Neoplastic}}~~

== Additional Info ==

*Acute promyelocytic leukemia (APML, APL) is a subtype of acute myeloid leukemia (AML), a cancer of the white blood cells.

*In APL, there is an abnormal accumulation of immature granulocytes called promyelocytes. The disease is characterized by a chromosomal translocation involving the retinoic acid receptor alpha (RARα or RARA) gene and is distinguished from other forms of AML by its responsiveness to all-trans retinoic acid (ATRA; also known as tretinoin) therapy.

*Acute promyelocytic leukemia was first characterized in 1957 by French and Norwegian physicians as a hyperacute fatal illness, with a median survival time of less than a week. Today, prognoses have drastically improved; 10-year survival rates are estimated to be approximately 77% according to one study

== Alternate ICD10s to consider coding instead or in addition ==

~~(turn these into links to the actual diagnosis articles if possible. For some that might make no sense.)~~

== Candidate [[Combined ICD10 codes]] ==

== Related CCI Codes ==

~~== Candidate [[Combined ICD10 codes]] ==~~

~~(put links to likely candidates coded with this one, eg. a cause for a trauma.)~~

== Related Articles ==

@@ Line 1: / Line 1: @@
 {{ICD10 transition status
-| OldDxArticle =| CurrentStatus = freshly automatically generated article
+| OldDxArticle =
+| CurrentStatus = reconciled
 | InitialEditorAssigned = Debbie Page-Newton
-| MinimumCombinedCodes =
 }}
 {{ICD10 dx
+| MinimumCombinedCodes =
 | ICD10 Code=C92.4
 | BugRequired=
 }}
+{{ICD10 category|Heme/immunology}}{{ICD10 category|Neoplastic}}{{ICD10 category|Leukemia}}
-{{ICD10 category|Heme/immunology}}{{ICD10 category|Neoplastic}}
 == Additional Info ==
+*Acute promyelocytic leukemia (APML, APL) is a subtype of acute myeloid leukemia (AML), a cancer of the white blood cells.
+*In APL, there is an abnormal accumulation of immature granulocytes called promyelocytes. The disease is characterized by a chromosomal translocation involving the retinoic acid receptor alpha (RARα or RARA) gene and is distinguished from other forms of AML by its responsiveness to all-trans retinoic acid (ATRA; also known as tretinoin) therapy.
+*Acute promyelocytic leukemia was first characterized in 1957 by French and Norwegian physicians as a hyperacute fatal illness, with a median survival time of less than a week. Today, prognoses have drastically improved; 10-year survival rates are estimated to be approximately 77% according to one study
+{{ICD10 Guideline leukemia vs lymphoma}}
+{{ICD10 Guideline Cancer}}
 == Alternate ICD10s to consider coding instead or in addition ==
-(turn these into links to the actual diagnosis articles if possible. For some that might make no sense.)
+{{ListICD10Category | categoryName = Leukemia}}
+== Candidate [[Combined ICD10 codes]] ==
+== Related CCI Codes ==
-== Candidate [[Combined ICD10 codes]] ==
+{{Data Integrity Check List}}
-(put links to likely candidates coded with this one, eg. a cause for a trauma.)
 == Related Articles ==
 {{Related Articles}}
 {{ICD10 footer}}
 {{EndPlaceHolder}}